Janice Sue Wen Chan

Dr. Janice Sue Wen Chan

Herbal Medicine Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Shah Alam, Selangor, Malaysia
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2021 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
XLXin Yi Lim
Xin Yi Lim
JCJanice Sue Wen Chan
Janice Sue Wen Chan
NJN. Japri
N. Japri
JLJune Chelyn Lee
June Chelyn Lee
TTTerence Yew Chin Tan
Terence Yew Chin Tan
Introduction. The Carica papaya L. leaf is gaining interest as a potential therapeutic agent for alleviating dengue- and non-dengue-associated thrombocytopaenia. In that regard, safety considerations are as important as efficacy potential. The safety evaluation of botanical products for human use is complicated by variable formulations, complex phytochemical composition, and extrinsic toxicants. This review aimed to systematically collate related safety clinical and preclinical data, as well as reports on herb-drug interactions of C. papaya leaf consumption. Methods. A systematic search using predetermined keywords on electronic databases (MEDLINE, Cochrane Library Central, LILACS, and Web of Science) and grey literature was conducted. Relevant clinical and preclinical studies were identified, screened, and analysed to present an overall safety profile of C. papaya leaf consumption. Results. A total of 41 articles were included (23 clinical, 5 ongoing trials, and 13 preclinical) for descriptive analysis on study characteristics, adverse reactions, toxicity findings, and herb-drug interactions, from which 13 randomised controlled and quasiexperimental trials were further assessed for risk of bias and reporting quality. Overall, C. papaya leaf consumption (in the form of juice and standardised aqueous extract) was well tolerated by adult humans for short durations (<five days) while one randomised controlled trial reported safe consumption of C. papaya leaf standardised aqueous extract in children (aged 112 years). Minor gastrointestinal side effects were most commonly reported. There are concerns about hepatotoxicity and reproductive toxicity in long-term use, supported by animal studies. Unfavourable herb-drug interactions with metformin, glimepiride, digoxin, ciprofloxacin, and artemisinin were accounted. Conclusion. C. papaya leaf consumption in adults is generally safe for short-term use though cautioned in pregnancy and people with liver impairment. It has potential herb-drug interactions with oral hypoglycaemic agents, p-glycoprotein substrates, and antibiotics with cation chelating properties.

30 November 2023 in Planta Medica
Verified
Journal Article
Open access
PDF file
JCJanice Sue Wen Chan
Janice Sue Wen Chan
XLXin Yi Lim
Xin Yi Lim
NJNorfarahana Japri
Norfarahana Japri
IAIda Farah Ahmad
Ida Farah Ahmad
TTTerence Yew Chin Tan
Terence Yew Chin Tan
Zingiber zerumbet, a plant native to tropical and subtropical Asia, has a vast range of traditional uses and has been continuously studied for its medicinal properties. However, a systematic methodological approach in evidence synthesis on the plantʼs efficacy is lacking, and there is a need to elicit the current research status of this plant. This scoping review was conducted to systematically explore and collate the available scientific evidence on the efficacy of Z. zerumbet and its main phytoconstituents in various formulations, their biological mechanisms, and their safety. Results included 54 articles consisting of animal studies, while there were no published human studies. Only half of the included studies provided adequate reporting on the quality-related details of Z. zerumbet formulations. Identified pharmacological activities were analgesic, anti-inflammatory, anti-diabetic, anti-hyperlipidemic, anti-neoplastic, immunomodulatory, antioxidant, antipyretic, hepatoprotective, nephroprotective, gastroprotective, and locomotor-reducing activities. Notably, the ethanolic extract of Z. zerumbet was found to be well tolerated for up to 28 days. In conclusion, Z. zerumbet and zerumbone have various pharmacological effects, especially in analgesic and anti-inflammatory models. However, there is still a pressing need for comprehensive safety data to conduct clinical trials.

1 January 2025 in Therapeutic Advances in Chronic Disease
Verified
Journal Article
Open access
JCJanice Sue Wen Chan
Janice Sue Wen Chan
MLMei Siu Lau
Mei Siu Lau
SRSITI HAJAR MUHAMAD ROSLI
SITI HAJAR MUHAMAD ROSLI
SMSiti Khadijah MK
Siti Khadijah MK
WSWan Nurul Nadia Wan Seman
Wan Nurul Nadia Wan Seman
XLXin Yi Lim
Xin Yi Lim
Background: With rising obesity rates worldwide, clinical trials focused on identifying effective treatments are increasing. While guidelines exist for pharmaceutical drugs targeting obesity, there are none for herbal medicine clinical trials for anti-obesity. Both industries refer to the same guidelines for clinical trials. Objectives: This scoping review aimed to gather information from herbal medicine anti-obesity randomised controlled trials (RCTs), analyse the methodologies and assess their alignment with international guidelines. Eligibility criteria: This review included RCTs of participants of all ages with obesity utilising herbal medicine with any comparators and focusing on various outcome measures. Sources of evidence: Only published journal articles were included. Charting methods: Articles were extracted from MEDLINE, CENTRAL and EMBASE using predetermined keywords. Relevant data, such as the study characteristics, types of herbal interventions and controls, treatment durations, outcome measures and safety monitoring methods were recorded in a table format for comparative analysis. Results: We included 99 RCTs that showed participant sample sizes ranging from 8 to 182, ages 18 to 80 years and body mass indexes (BMIs) between 25 and 49.9 kg/m2. Herbal interventions used single herbs ( n = 57) and mixtures ( n = 42), given for 14 days to 56 weeks. Studies implementing diet modifications include restricted calorie diets ( n = 35), food-portion controlled diets ( n = 7) and fixed calorie diets ( n = 7). Of the 28 studies implementing exercise, most were of moderate intensity ( n = 22). All studies collected BMI and weight as primary outcomes. Body fat composition was measured in over 50% of studies using a body analyser ( n = 57). Waist, hip and abdominal circumferences were infrequently measured. Radiological tools used include dual-energy X-ray absorptiometry ( n = 16), computed tomography scans ( n = 10) and ultrasound ( n = 2). Safety monitoring methods were reported in most studies ( n = 76). Conclusion: In conclusion, almost 50% of the studies adhered to international pharmaceutical clinical trial guidelines, addressing dietary, lifestyle, physical activity and cardiovascular risk factors. Nonetheless, more herbal anti-obesity studies need to consider the assessment of weight maintenance.

29 January 2026 in Discover Food
Verified
Journal Article
Open access
PDF file
TTTerence Yew Chin Tan
Terence Yew Chin Tan
PKPuteri Sofia Nadira Megat Kamaruddin
Puteri Sofia Nadira Megat Kamaruddin
SRSiti Hajar Muhamad Rosli
Siti Hajar Muhamad Rosli
HLHan Yin Lim
Han Yin Lim
JCJanice Sue Wen Chan
Janice Sue Wen Chan
SISophia Rasheeqa Ismail
Sophia Rasheeqa Ismail
Background: Sacha inchi ( Plukenetia volubilis ), a member of the Euphorbiaceae family, has long been valued for its nutritional and medicinal properties, including use in food and cosmetic industries as a poultice to soften, revitalize, and rejuvenate the skin. Its health benefits are attributed to its rich content of essential nutrients and phytocompounds. Objective: This review systematically explores and compiles current scientific evidence on the efficacy of Sacha inchi. Methods: Publications were identified and selected according to the PRISMA guidelines, with predetermined inclusion criteria. Databases searched included Web of Science, CENTRAL, LILACS, Scopus, PubMed®, and EBSCOhost. Results: Thirteen articles were included, primarily using oil-based extracts or products, with treatment durations ranging from one month to 20 months in human studies and 75 min to 3.5 months in animal studies. Clinical findings support the benefits of Sacha inchi for metabolic syndrome, cognitive enhancement, dry eye syndrome, and dermatological health, while animal studies suggest potential effects in managing hypertension, hyperlmia, and offering neuroprotection. Conclusions: However, there remains a lack of comprehensive evaluation of specific formulations or extracts in both clinical and preclinical settings. Further research is needed, particularly regarding safety data at higher doses and for prolonged use.

13 November 2025 in JMIR Research Protocols
Verified
Journal Article
Open access
NHNurul Amalina Khairul Hasni
Nurul Amalina Khairul Hasni
SRSAKSHALENI RAJENDIRAN
SAKSHALENI RAJENDIRAN
NNNurul Athirah Naserrudin
Nurul Athirah Naserrudin
NSNurul Farehah Shahrir
Nurul Farehah Shahrir
TTTerence Yew Chin Tan
Terence Yew Chin Tan
SRSiti Aishah Rashid
Siti Aishah Rashid
Background: In recent years, the rapid emergence and global spread of dengue has become a public health burden. Clinical surveillance alone has limited capacity, with delayed detection of upcoming outbreaks. Hence, the potential use of wastewater-based surveillance (WBS) for early detection of incoming surges of dengue cases could complement proactive public health action. However, there are still substantial gaps in the standard approach for sampling and detection methods in dengue WBS. Objective: This review aims to determine the current methodological approach for the detection of dengue virus (DENV) in wastewater across geographical areas. Methods: The review will be conducted systematically following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. In the initial stage, peer-reviewed publications from PubMed, Embase, Scopus, and Web of Science will be searched using predefined terms such as “Dengue” and “WBS.” Keywords will be adjusted to suit each database to identify studies related to DENV WBS from inception until June 2025. Subsequently, the references from relevant articles will be screened for eligibility. All data will be extracted from full-text articles highlighting the characteristics and methodological context of the investigated DENV WBS using a standardized form. The ROBINS-I (Risk of Bias in Non-randomized Studies - of Interventions) tool and the GRADE (Grading of Recommendations Assessment, Development, and Evaluations) system will be used to assess study bias and the quality of the evidence. Further descriptive analysis and meta-analysis will be applied to evaluate the methodologies for DENV WBS. Results: The data on DENV detection in wastewater will be synthesized by analyzing sampling techniques, viral detection method, study sites, geographic locations and dengue serotype. A meta-analysis will be conducted using a random-effects model if data are heterogeneous, with pooled estimates reported as 95% CIs. Heterogeneity will be assessed using I ² and chi-square tests, with subgroup and sensitivity analyses conducted as needed. Findings will be reported in accordance with PRISMA 2020. As of October 2025, records have been identified from the databases and data analysis is expected to be completed by the first quarter of 2026. Conclusions: This protocol outlines a systematic approach to identifying and evaluating existing methods for detecting DENV in wastewater. This research aims to provide valuable insights into best practices for dengue surveillance and offer guidance for future research by highlighting current strengths and limitations in the field.

30 April 2026 in Viruses
Verified
Journal Article
Open access
PDF file
SRSiti Aishah Rashid
Siti Aishah Rashid
SRSAKSHALENI RAJENDIRAN
SAKSHALENI RAJENDIRAN
NSNurul Farehah Shahrir
Nurul Farehah Shahrir
NNNurul Athirah Naserrudin
Nurul Athirah Naserrudin
TTTerence Yew Chin Tan
Terence Yew Chin Tan
NHNurul Amalina Khairul Hasni
Nurul Amalina Khairul Hasni
Dengue fever, with a high proportion of asymptomatic infections, poses a major global public health challenge that traditional surveillance systems frequently underestimate. Wastewater-based epidemiology (WBE) has emerged as a promising approach to monitoring infectious diseases beyond enteric viruses. Dengue virus is shed in urine, feces, and saliva, providing a biological basis for wastewater detection alongside clinical surveillance. This systematic review and meta-analysis synthesize current evidence on dengue virus (DENV) detection in wastewater and evaluate methodological factors influencing detection success in WBE. A systematic literature search using selected databases and predetermined keywords, followed by eligibility screening, resulted in ten studies being included, covering community surveillance and experimental trials. DENV ribonucleic acids (RNA) were most consistently detected and enriched in wastewater solids, indicating this matrix as the most reliable for surveillance. Among concentration methods, ultrafiltration achieved the highest viral recovery efficiency, while reverse transcription digital polymerase chain reaction (RT-dPCR) demonstrated superior sensitivity and precision compared to those of reverse transcription quantitative polymerase chain reaction (RT-qPCR), particularly at low viral concentrations. Storage at −80 °C was critical for preserving RNA integrity. The meta-analysis yielded a pooled DENV positivity rate of 24% (95% CI: 20–28%) after exclusion of outliers. Overall, solid-phase analysis combined with RT-dPCR represents the most sensitive methodological approach across the included studies. Harmonized protocols are needed to support future translation of dengue WBE into community surveillance as current evidence mainly demonstrates methodological feasibility and provides a technical foundation for future public health integration. Therefore, further longitudinal and multi-site validation is required to establish its broader applicability for dengue surveillance.